Thornberry Nancy sold VRTX
May 1, 2026 · Form 4 insider transaction
Thornberry Nancy sold 398 shares of Vertex Pharmaceuticals Incorporated, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
398
Price
N/A
Total value
N/A
InsiderThornberry Nancy
Role—
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after2,109
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units.